Deficiency Index

F744 citations in Hawaii

Dementia care · Quality of Life and Care Deficiencies

Provide the appropriate treatment and services to a resident who displays or is diagnosed with dementia.

Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.

F744 in Hawaii. Pick another state for the same tag.

No F744 citations were recorded in Hawaii for 2025. That means none appear in the CMS file for that year — not that the requirement does not apply.

In the surveyor’s words

What Hawaii surveyors wrote

F744 findings written in Hawaii, one from each severity band recorded here, most serious first.

Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.

D · No harm, potential for more than minimal, isolatedNovember 18, 2022

Based on record review and interview with staff members, the facility did not assure a resident with dementia received appropriate interventons to attain or maintain her highest practicable psychosocial well-being. Findings include: Resident (R)180 was admitted on [DATE]. diagnoses [MEDICAL RECORD OR PHYSICIAN ORDER] & agitation (04/26/22). Record review notes R180 is prescribed [CONDITION(S)] medications (used to treat mental health disorders): alpralozam, 1 mg (miligram), give one tablet three times a day for anxiety disorder; [MEDICATION(S)] tablet 0.5 mg, give 0.25 mg by mouth one time time a day for dementia with [CONDITION(S)]; [MEDICATION(S)], 20 mg, give 20 mb by mouth one time a day for depressive disorder secondary to dementia; and [MEDICATION(S)] tablet 15 mg, give one tablet… …

Life Care Center of Hilo

What else Hawaii surveyors cite →

Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction